year 11, Issue 1 (March - April 2017)                   Iran J Med Microbiol 2017, 11(1): 30-38 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Babapour E, Haddadi A, Mirnejad R, Angaji S, Amirmozafari N. Study of drug resistance and ompA gene existence in clinical Acinetobacter baumannii isolates . Iran J Med Microbiol. 2017; 11 (1) :30-38
1- Department of Microbiology, Karaj Branch, Islamic Azad University, Karaj, Iran
2- Molecular Biology Research Center, Baqiyatallah University of Medical of Sciences. Tehran, Iran
3- Department of Cell and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran
4- Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran ,
Abstract:   (7904 Views)

Background and Aim: Acinetobacter baumannii is one of the most important multi drug-resistant species associated with nosocomial infections. Several factors involve in resistance to drug and its pathogenicity. Of these factors, OmpA protein plays a crucial role. Therefore, the aim of current research was to assess resistance to drug and also ompA gene existence in
A. baumannii isolated from clinical sources.

Materials and Methods: Firstly, clinical samples were collected from Imam Khomeini, Milad and Motahari Hospitals during 2015-2016 years and the final confirmation were done by using biochemical methods. Afterwards, susceptibilities to antibiotics of different classes were determined by disc diffusion method and presence of ompA gene was checked by using PCR method and verified by sequencing.

Results: The results show that of 650 clinical samples, 156 (24%) of isolates were formed of A. baumannii and mostly showed resistance to different classes of antibiotics. 92.95% of isolates were multi drug resistance (MDR) and finally 86.53% were extremely drug resistance (XDR). All of them contained ompA gene.

Conclusions: Existence of multi drug resistance in most isolates as well as presence of ompA in all samples can cause bacterial virulence and drug resistance. It seems essential to provide continuous monitoring and determination of antibiotic susceptibility of clinical A. baumannii, decrease the moral and material damage caused by the bacteria.

Full-Text [PDF 739 kb]   (1999 Downloads)    
Type of Study: Original | Subject: Medical Bacteriology
Received: 2016/05/29 | Accepted: 2017/01/21 | ePublished: 2017/03/16

1. Smani Y, Fàbrega A, Roca I, Sánchez-Encinales V, Vila J, Pachón J. Role of OmpA in the Multidrug Resistance Phenotype of Acinetobacter baumannii. Antimicrob Agents Chemother 2014; 58(3): 1806–8. [PubMed]
2. Ardebili A, Rastegar Lari A, Talebi M. Correlation of ciprofloxacin resistance with the AdeABC efflux system in Acinetobacter baumannii clinical isolates. Ann Lab Med 2014; 34(6): 433-38. [PubMed]
3. McConnell MJ, Pachón J. Expression, purification, and refolding of biologically active Acinetobacter baumannii OmpA from Escherichia coli inclusion bodies. Protein Expr Purif 2011; 77(1): 98-103. [PubMed]
4. Gaddy JA, Tomaras AP, Actis LA. The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells. Infect Immun 2009; 77(8): 3150-60. [PubMed]
5. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18(3): 268-81. [PubMed]
6. Rodríguez-Baño J, Cisneros JM, Fernández-Cuenca F, Ribera A, Vila J, Pascual A, et al. Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals. Infect Control Hosp Epidemiol 2004; 25(10): 819-24. [PubMed]
7. Choi CH, Lee EY, Lee YC, Park TI, Kim HJ, Hyun SH, et al. Outer membrane protein 38 of Acinetobacter baumannii localizes to the mitochondria and induces apoptosis of epithelial cells. Cell Microbiol 2005; 7(8): 1127-38. [PubMed]
8. Choi C, Lee J, Lee Y, Park T, Lee Je. Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells. BMC Microbiol 2008; 8(216): 1-11. [PubMed]
9. Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. Identification of Acinetobacter baumannii by detection of the bla OXA-51-like carbapenemase gene intrinsic to this species J Clin Microbiol 2006; 44: 2974-76. [PubMed]
10. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. Twenty-Fourth Informational Supplement; 2014.
11. Bayram Y, parlak M, Aypak C, Bayram I. Three–year reviwe of bacteriological profile and antibiogram of burn wound isolates in Van Turkey. Int J Med Sci2013; 10(1): 19-23. [PubMed]
12. Joly-Guillou ML. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect 2005; 11(11): 868-73. [PubMed]
13. Neonakis IK, Spandidos DA, Petinaki E. Confronting multidrug-resistant Acinetobacter baumannii: a review. Int J Antimicrob Agents 2011; 37(2): 102-9. [PubMed]
14. Vafaei S, Mirnejad R, Amirmozafari N, Imani Foladi A, Masjedian F. Broad-spectrum beta-lactamases and frequency of antibiotic resistance in Acinetobacter baumannii strains isolated from clinical samples by phenotypic methods. Journal of Infectious Diseases and Tropical Medicine 2013; 6: 39-44 [in Persian].
15. Constantiniu S, Romaniuc A, Iancu, SL, Filimon R, Taraşi I. Cultural and biochemical characteristics of Acinetobacter spp. Strains isolated from hospital units. J Prev Med 2004; 12: 35-42 [Article]
16. Rahmani M, Yaghoubnezhad-Zangeneh G, Oshaghi M, Talebi M, Amirmozafari N. Identification of five phylogenic groups of carbapenemase (bla OXA-23,24,51,58,143) in Acinetobacter baumannii strains isolated from clinical samples in Iran by multiplex PCR. Der Pharma Chemica 2015; 7(7): 11-16.
17. Asadollahi P, Akbari M, Soroush S, Taherikalani M, Asadollahi K, Sayehmiri K, et al. Antimicrobial resistance patterns and their encoding genes among Acinetobacter baumannii strains isolated from burned patients. Burns 2012; 38(8): 1198–203. [PubMed]
18. Mak JK, Kim MJ, Pham J, Tapsall J, White PA. Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother 2009; 63(1):47-54. [PubMed]
19. Hujer K, Hujer A, Hulten E, Bajaksouzian S, Adams J, Donskey C, et al. Analysis of Antibiotic Resistance Genes in Multidrug-Resistant Acinetobacter sp. Isolates from Military and Civilian Patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother 2006; 50(12): 4114-23. [PubMed]
20. Wang DH, Sheng EH, Chang YY, Wang LH, Lin HC, Chen ML, et al. Health care- associated outbreak due to pan- drug resist ant Acinetobacter baumannii in a surgical unit. j Hosp Infect 2003; 53(2): 97-102. [PubMed]
21. Smolyakov R, Borer A, Riesenberg K, Schlaeffer F, Alkan M, Porath A, et al. Nosocomial multi-drug resistant Acinetobacter baumannii blood stream infection: risk factors and outcome with ampicillin-sulbactam treatment. J Hosp Infect 2003; 54(1): 32-8. [PubMed]
22. Shakibaie M R, Adeli S, Salehi MH .Antibiotic resistance patterns and extended-spectrum β-lactamase production among Acinetobacter spp. isolated from an intensive care Unit of a hospital in Kerman, Iran. Antimicrob Resist Infect Control 2012; 1(1): 1-8. [PubMed]
23. Sinha M, Srinivasa H, Macaden R. Antibiotic resistance profile and Extended spectrum beta-lactamase production in Acinetobacter species. Indian J Med Res 2007; 126(1): 63-67.
24. Sugawara E, Nikaido H. OmpA is the principal nonspecific slow porin of Acinetobacter baumannii. J Bacteriol 2012; 194(15): 4089-96. [PubMed]

Add your comments about this article : Your username or Email:

Send email to the article author

© 2020 All Rights Reserved | Iranian Journal of Medical Microbiology

Designed & Developed by : Yektaweb | Publisher: Farname Inc